Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income (loss)	$ 6,938	$ (12,000)	$ 6,890
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	86,376	76,871	63,677
Amortization of deferred financing costs	3,136	2,230	1,730
Amortization of above/below-market assumed debt	114	114	114
Noncash revenue adjustments	(5,119)	(3,699)	(1,632)
Amortization of deferred losses (gains) on interest rate swaps	2,859	(3,789)	(2,124)
Stock-based compensation expense	5,898	5,656	4,823
Gain on sales of real estate, net	(7,686)	(1,876)	(1,175)
Provisions for impairment	17,268	29,969	7,083
Loss on debt extinguishment	46	0	128
(Gain) loss on involuntary conversion of building and improvements	(45)	502	(78)
Changes in assets and liabilities, net of assets acquired and liabilities assumed:
Other assets, net	(102)	(1,200)	(1,237)
Accounts payable, accrued expenses, and other liabilities	494	(946)	3,696
Lease incentive payments	(667)	(1,668)	(1,740)
Net cash provided by operating activities	109,510	90,164	80,155
Cash flows from investing activities
Acquisitions of real estate	(598,073)	(479,039)	(340,451)
Real estate development and improvements	(9,426)	(40,334)	(78,798)
Investment in mortgage loans receivable	(37,425)	(29,543)	(72,429)
Principal collections on mortgage loans receivable	31,251	24,870	1,482
Proceeds from sale of mortgage loans receivable	10,480	0	0
Earnest money deposits	(6,273)	(67)	(265)
Purchase of computer equipment and other corporate assets	(52)	(8)	(35)
Proceeds from sale of real estate	160,631	90,843	38,465
Proceeds from the settlement of property-related insurance claims	45	403	78
Net cash used in investing activities	(448,842)	(432,875)	(451,953)
Cash flows from financing activities
Issuance of common stock in public offerings, net	188,341	135,475	271,389
Payment of common stock dividends	(70,230)	(63,457)	(51,675)
Payment of OP unit distributions	(358)	(369)	(407)
Payment of restricted stock dividends	(277)	(599)	(148)
Principal payments on mortgages payable	(164)	(155)	(138)
Proceeds under revolving credit facilities	349,000	392,000	361,000
Repayments under revolving credit facilities	(588,000)	(233,000)	(394,000)
Proceeds from term loans	518,675	100,000	150,000
Principal payments on term loans	(43,675)	0	0
Repurchase of common stock for tax withholding obligations	(753)	(1,498)	(688)
Payment of deferred offering costs	(1,036)	(1,295)	(878)
Payment of deferred financing costs	(12,044)	0	(3,271)
Net cash provided by financing activities	339,479	327,102	331,184
Net change in cash, cash equivalents, and restricted cash	147	(15,609)	(40,614)
Cash, cash equivalents, and restricted cash at beginning of the period	14,320	29,929	70,543
Cash, cash equivalents, and restricted cash at end of the period	14,467	14,320	29,929
Supplemental disclosures of cash flow information:
Cash paid for interest, net of amounts capitalized	44,028	30,295	18,336
Cash (received) paid for income taxes, net	(64)	(31)	628
Supplemental disclosures of non-cash investing and financing activities:
Dividends declared and unpaid on restricted stock	550	376	501
Deferred offering costs included in accounts payable, accrued expenses, and other liabilities	0	35	7
Loan Origination Fees On Mortgage Loans Receivable, Accrued Not Yet Received	230	200	0
Cash flow hedge change in fair value	(17,709)	5,058	(12,698)
Mortgage loan receivable settled in exchange for acquisition of real estate	0	0	4,673
Increase in mortgage loan receivable in exchange for disposition of real estate	8,450	20,102	1,837
Refinancing of mortgage loan receivable	0	0	1,327
Mortgage note assumed at fair value	4,888	0	0
Accrued capital expenditures and real estate development and improvement costs	3,007	4,500	5,686
Accrued lease incentives	$ 0	$ 368	$ 0